Berberine pretreatment enhances the homing and anti-inflammatory efficacy of dental pulp mesenchymal stem cells in TNBS-induced inflammatory bowel disease via activating the CXCR4/SDF-1 signaling pathway
Open Access
- 25 April 2026
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 180, 116716
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Jiangsu Province
This publication has 27 references indexed in Scilit:
- A novel pH-responsive berberine-loaded attapulgite microsphere for IBD therapy via the regulation of gut immunity and floraInternational Journal of Pharmaceutics, 2025
- Berberine, a natural alkaloid: Advances in its pharmacological effects and mechanisms in the treatment of autoimmune diseasesInternational Immunopharmacology, 2024
- Exosomes derived from mesenchymal stem cells containing berberine for ulcerative colitis therapyJournal of Colloid and Interface Science, 2024
- Inhibition of inflammation by berberine: Molecular mechanism and network pharmacology analysisPhytomedicine, 2024
- Inflammatory Bowel DiseasePrimary Care: Clinics in Office Practice, 2023
- Berberine attenuates epithelial mesenchymal transition in bleomycin-induced pulmonary fibrosis in mice via activating A2aR and mitigating the SDF-1/CXCR4 signalingLife Sciences, 2023
- Enhanced migration and immunoregulatory capacity of BMSCs mediated by overexpression of CXCR4 and IL-35Molecular Immunology, 2022
- Modifying strategies for SDF-1/CXCR4 interaction during mesenchymal stem cell transplantationGeneral Thoracic and Cardiovascular Surgery, 2021
- SDF-1 mediates mesenchymal stem cell recruitment and migration via the SDF-1/CXCR4 axis in bone defectJournal of Bone and Mineral Metabolism, 2020
- Rerouting mesenchymal stem cell trajectory towards epithelial lineage by engineering cellular nicheBiomaterials, 2018